ITTN - Co. Chairman of the Board.
Benjamin Soffer joined the Technion as CEO of T3 - Technion Technology Transfer office in 2005. As part of his duties at T3, Mr. Soffer is responsible for the establishment of startup companies and the commercialization of technologies arising from the Technion research. His Experience spans over 20 years in the areas of investment, industry and government in Israel, Europe, and the United States. In addition, Mr. Soffer serves as CEO of AMIT, a Technion hub for biomedical innovation; Chairman of T-Factor, the Technion engineering accelerator and , and Chairman of the ITTN – The Israeli Technology Transfer Organization. In addition Mr. Soffer serves on the boards of directors of numerous high growth companies. Prior to his position at the Technion, Mr. Soffer served as managing director of TopNotch Capital - and was as an investment advisor at Highbridge Capital. Between 1999 and 2003 he served as Israel's Economic attaché in Boston. There, Mr. Soffer was responsible for enhancing economic and business relations between Israel and the US Northeast region through private equity investments, joint ventures and trade. Prior to his tenure in Boston, Mr. Soffer served as special advisor to Dr. Orna Berry, Israel's chief scientist at the Ministry of Industry and Trade, where played a pivotal role in the initiation and implementation of innovative R&D programs. A certified lawyer in Israel and in the state of New York, Mr. Soffer has interned at Israel's Supreme Court and studied law at Tel Aviv University and at Ludwig Maximilian University in Munich. Additionally, he studied economics and business administration at Bar - Ilan University.
ITTN – Director
Gil Granot-Mayer holds an MBA degree from the Leon Recanati Graduate School of Business Administration and an LL.B. degree from Tel-Aviv University. Mr. Granot-Mayer was appointed as Yeda’s C.E.O in 2016 after having served as Deputy C.E.O and General Counsel of Yeda for 10 years. Prior to joining Yeda, Mr. Granot-Mayer worked in prominent law firms both as a commercial lawyer and as a litigator specializing in Intellectual Property, Cyberspace Law, E-commerce and Banking.
Mr. Granot-Mayer is a frequent speaker in various forums covering issues related to Intellectual Property, licensing and technology transfer.
Gil served in the Israeli Navy as a submarine crewmember during his extended military service.
Gil is married and has three children.
ITTN – Director
Dr. Luria received her PhD from the Weizmann Institute of Science, did her Post Doctorate at Stanford Medical School, and served as a visiting scientist at the Massachusetts Institute of Technology.
Dr. Luria has a unique combination of life science education, exhaustive research in cellular, molecular, genetic, immunology and virology fields coupled with extensive management and business experience in biomedical start-up companies.
Dr. Luria has expertise in fund-raising and fostering strategic partnerships with pharmaceutical and biotechnology companies worldwide and has demonstrated capabilities in developing biological products for the BioMedical companies.
Dr. Luria has comprehensive experience in biomedical technology assessment, due diligence, technical representation with strategic planning, management and development of biotechnology companies.
From 1999 to 2017, Dr. Luria has been involved in the establishment of more than 40 biomedical startup companies that raised over 260 Million USD in their seed stage.
From 2007 to Present – Dr. Luria serves as the Sheba Medical Center Technology Transfer Company Manager
• Raising Research Funds from Industrial resources to enhance Sheba's patent portfolio
• Commercialization of over 55% of the Sheba's IP portfolio - identification of potential partners, commercial and legal negotiation, preparing and executing licensing agreements with third parties.
• Managing Licensing Agreements and Inter Institutional Agreements.
• Board Member in Sheba's company spinoffs.
Tel: +972-3-5305998 Fax: +972-3-5305944 Cell: +972-052-6667277